ArticleInflammopharmacology2026

Targeting tie-2 receptor with rebastinib (DCC-2036) for angiogenesis Inhibition in early-stage arthritis : enhanced efficacy through liposomal sustained release.

Minuk Jeong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.